Journals / Sağlık Bilimlerinde İleri Araştırmalar Dergisi / 2020 / Cilt: 3 - Sayı: S1

COVID-19 Pandemia: Global Consequences for Oncology

COVID-19 Pandemisi ve Dünyada Onkolojide Etkileri

Pages
99–105
Publication Date
2020-05-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Guidelines provided by the Ministy of Health and international guidelines should be followed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:People with cancer and cancer survivors, particularly those with compromised immune systems, are prone to infections and are at high risk for the new coronavirus 2019 (COVID-19) infection.
📊
Key Findings & Data:The incidence and prevalence of the COVID-19 infection in cancer patients are higher than the general population according to data reported from China, where COVID-19 was first identified and other countries.
💡
Conclusion & Impact:Guidelines provided by the Ministy of Health and international guidelines should be followed.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:COVID-19 · SARs-CoV2 · kanser

Abstract

People with cancer and cancer survivors, particularly those with compromised immune systems, are prone to infections and are at high risk for the new coronavirus 2019 (COVID-19) infection. The incidence and prevalence of the COVID-19 infection in cancer patients are higher than the general population according to data reported from China, where COVID-19 was first identified and other countries. Based on available evidence, children seem to be at a lower risk for COVID-19 than adults. Oncology specialists and other providers involved in diagnosis, treatment, and follow-up of patients with cancer must consider how to balance delay in cancer diagnosis or treatment against the risk for potential COVID-19 exposure. Patients, caregivers and hospital staff members should be keen on hand washing, correct use of masks. Healthcare workers should use the appropriate personal protective equipment. Physicians and nurses dedicated to Hematology-Oncology and Stem Cell Transplant Units shall not attend any COVID-19 patients or services. Guidelines provided by the Ministy of Health and international guidelines should be followed.

Özet

Kanser tedavisi (kemoterapi, radyoterapi, kök hücre nakli, immünoterapi vd) gören veya yakın zamanda tedavisi bitmiş olan gerek erişkin, gerek çocuk hastalar bağışıklık sistemleri baskılandığından enfeksiyona duyarlıdırlar. Kanser tedavisi gören hastalar ve kanser geçirmiş olan kişiler COVID-19 pandemisinde riskli bir grubu oluşturmaktadırlar. Hastalığın ilk görüldüğü Çin'de ve diğer ülkelerde kanser hastalarında, genel populasyona oranla COVID-19 infeksiyonunun insidans ve prevalansının daha yüksek olduğu, komorbiditelerin olmasının da riski artırdığı bildirilmektedir. Çocukların erişkinlere oranla daha düşük riskte oldukları bildirilmektedir. Kanser hastalarının tanı, tedavi ve takibinde görev alan onkologlar ve idarecilerin hastaların tanı ve tedavilerinin devamını sağlarken, infeksiyona maruz kalmalarını önlemeleri önemlidir. Bu nedenle hastalar, onlara bakım veren yakınları ve sağlık çalışanları başta el yıkama ve cerrahi maske takmak olmak üzere gerekli kişisel korunma önlemlerine azami ölçüde dikkat etmelidir. Kanser hastalarıyla uğraşan hekim ve sağlık personelinin, COVID enfeksiyonu servislerinde çalıştırılmaması önerilir. Kanser hastalarının takip ve tedavi süreçlerinde COVID-19 enfeksiyonundan korunmada Sağlık Bakanlığının önerileri, ulusal ve uluslararası kılavuzlar güncel olarak takip edilmeli, bu önerilere göre hareket edilmelidir.

🔖

Cite This Article

KEBUDİ, R. (2020). COVID-19 Pandemia: Global Consequences for Oncology. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, Cilt: 3 - Sayı: S1, 99–105. https://ajindex.com/articles/215613

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. World Health Organization. Coronavirus Disease Pandemic. [online]. Website https:// www.who.int/emergencies/diseases/novelcoronavirus-2019 [02/05/ 2020] 2. Stoecklin BS, Rolland P, Silue Y, Mailles A, Campese C et al. Investigation Team. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations, and control measures, January 2020. Eurosurveillance 2020
  2. 25(6):2000094. 3. T.C. Sağlık Bakanlığı Korona Tablosu https:// covid19.saglik.gov.tr/ (02/05/ 2020) 4. American Society of Clinical Oncology COVID-19 Resources https://www.asco.org/ asco-coronavirus-information (02/05/2020) 5. Bouffet E, Challinor J, Sullivan M, Biondi A, Rodriguez-Galindo C, Pritchard-Jones K. Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences. Pediatric Blood and Cancer. 2020 Apr 2:e28327. doi: 10.1002/pbc.28327. [Epub ahead of print]. 6. Michael Sullivan, Eric Bouffet, Carlos Rodriguez-Gallindo, Sandra Luna-Fineman, Muhammad Saghir Khan, Pam Kearns, Doug Hawkins, Julia Challinor, Lisa Morrissey, Jorg Fuchs, Karen Marcus, Adriana Balduzzi, Luisa Bassett, Miguela Caniza, Justin N Baker, Laila Hessissen, Rejin Kebudi, Richard Sullivan, Kathy Pritchard-Jones. The COVID-19 PANDEMIC: A Rapid Global response for Children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, St Jude Global and the WHO., Pediatric Blood and Cancer, 2020 (in press) https://doi. org/10.22541/au.158777298.87289192/v2 7. Jazieh AR, Alenazi TH, Alhejazi A Al Safi F, Al Olayan A. Outcome of Oncology Patients Infected With Coronavirus. JCO Global Oncol 6: 471-475. 8. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020
  3. 21(3):335-337. 9. Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and Cancer: Lessons from a pooled analysis. JCO Global Oncology 2020
  4. https://doi.org/10.1200/GO.20.00097. 10. Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak.Cancer Discovery. Published Online first on April 28, 2020
  5. DOI: 10.1158/2159-8290.CD-20-0422. 11. Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, Cruz C, Do Patients with Cancer Have a Poorer Prognosis of COVID-19? An Experience in New York City., Annals of Oncology (2020), https://doi.org/10.1016/j. annonc.2020.04.006. 12. Hasan Tezer, Tuğba Bedir Demirdağ. Novel coronavirus disease (